Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

International, Multicenter, Randomized, Double-blind, Comparative Clinical Study of the Efficacy, Safety, Pharmacokinetics, and Immunogenicity of GNR-067 and Lucentis® in Patients With Neovascular (Wet) Age-related Macular Degeneration

NCT04667039 is registered in ClinicalTrials.gov with AO GENERIUM as lead sponsor.

NCT NCT04667039
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04667039 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
International, Multicenter, Randomized, Double-blind, Comparative Clinical Study of the Efficacy, Safety, Pharmacokinetics, and Immunogenicity of GNR-067 and Lucentis® in Patients With Neovascular (Wet) Age-related Macular Degeneration
Lead sponsor
AO GENERIUM
Phase
Phase 3
Overall status
Unknown status
Start date
March 20, 2022
Completion date
September 15, 2024
Enrollment
408 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

age related macular degeneration (armd)